stockrow
Friday 6 November 2026
Export INFU’s income statement to Excel — free account
InfuSystems Holdings, Inc.
INFU Healthcare Medical Devices
InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024.
- Revenue
- +2.59%
- EPS
- +33.3%
- Free cash flow
- −66.5%
- Total debt
- −22.5%
Quarter to June 2026, against a year earlier
13.73
0.17
+1.25%
Follow INFU
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 15.03% | 13.89% | 11.54% | 9.95% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
9 | 8 | 8 | 8 | |
| 8.61% | 7.80% | 6.49% | 5.41% | ||
ROIC |
10.55% | 10.56% | 10.10% | 8.96% | |
Return on Tangible Assets |
32.89% | 34.79% | 33.96% | 26.94% | |
Average Days of Receivables |
69.28 | 61.46 | 58.28 | 62.90 | |
Free Cash Flow per Share |
0.75 | 0.97 | 0.92 | 0.92 | |
Free Cash Flow |
15.14 | 19.62 | 19.03 | 18.76 | |
Capital Expenditures |
(8.23) | (3.98) | (5.38) | (6.45) | |
| Other line items | |||||
Cash ROIC |
18.80% | 24.37% | 23.75% | 24.25% | |
Accounts Receivable Turnover |
5.55 | 5.95 | 6.51 | 5.99 | |
Accounts Payable Turnover |
6.67 | 6.84 | 6.11 | 6.65 | |
Inventory Turnover |
10.90 | 10.33 | 10.59 | 10.25 | |
Average Days of Payables |
53.74 | 57.08 | 62.55 | 58.10 | |
Days of Inventory on Hand |
33.03 | 34.56 | 31.16 | 32.40 | |
Tax Rate |
(0.30) | (0.33) | (0.38) | (0.41) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
48.20% | 47.69% | 47.67% | 47.68% | |
Share Based Compensation of Revenue |
3.54% | 3.15% | 3.04% | 3.03% | |
Interest Coverage |
12.06 | 10.58 | 9.18 | 7.73 | |
Operating CF/Net income |
2.74 | 2.98 | 3.68 | 4.56 | |
Depreciation/Fixed assets |
4.43 | 4.14 | 3.98 | 3.68 | |
Capex/Depreciation |
(0.62) | (0.30) | (0.40) | (0.48) | |
Revenue per Share |
7.14 | 7.05 | 6.94 | 6.91 | |
Operating CF per Share |
1.16 | 1.17 | 1.18 | 1.24 | |
Capex per Share |
(0.41) | (0.20) | (0.26) | (0.32) | |
Capex to Sales |
0.06 | 0.03 | 0.04 | 0.05 |
Columns are period end dates